Illinois Ventures

Illinois Ventures

Illinois Ventures launched in 2002 as a for-profit early-stage investment firm with a mandate to back companies rooted in University of Illinois research and intellectual property. Nancy Sullivan has served as CEO and Managing Director, overseeing the firm's bridge function between a sprawling public research university and the venture capital market. The firm's unique standing rests on its privileged access to deal flow originating from the University of Illinois system, a top-tier research institution with annual R&D expenditures exceeding $1 billion. The firm deploys capital primarily through direct equity investments at the pre-seed, seed, and Series A stages, occasionally extending to Series B. Sectors align with the university's research strengths — enterprise software, digital health, AI/ML, agricultural technology, industrial technology, and energy transition. Confirmed portfolio holdings include companies spun out of university labs such as diagnostic platform Prenosis, and past engagements with materials science ventures like Natural Fiber Welding. Geographically, the portfolio concentrates in Illinois, with activity in the broader Midwest and occasional positions on the coasts where university founders relocate. Illinois Ventures does not publicly disclose assets under management or total deployment figures. The firm operates from Chicago, positioning itself between the university community and the city's growing venture ecosystem. In September 2023, Illinois Ventures participated in a $40 million Series B funding round for a University of Illinois-affiliated healthtech company, demonstrating continued activity in the university's commercialization pipeline. The firm maintains a close operating relationship with the university's Office of Technology Management, which funnels a stream of disclosed inventions into the firm's deal pipeline. The key structural differentiator is the firm's embedded position inside a major public research university's technology-transfer apparatus. Unlike a generalist VC, Illinois Ventures operates with a mandate to catalyze economic development from state-funded research. This creates an unusually dense, proprietary deal flow that is difficult for outside funds to replicate, even as it constrains the firm's geographic and sector scope to the university's laboratory output.